 | Up a level |
Journal Article
Blohmer, Jens-Uwe, Link, Theresa, Kuemmel, Sherko, Untch, Michael, Just, Marianne, Fasching, Peter A., Schneeweiss, Andreas, Wimberger, Pauline, Stoetzer, Oliver, Huober, Jens, Thill, Marc, Jackisch, Christian, Rhiem, Kerstin, Hanusch, Claus, Denkert, Carsten, Engels, Knut, Nekljudova, Valentina and Loibl, Sibylle (2020). Investigating denosumab as an add-on treatment to neoadjuvant chemotherapy and two different nab-paclitaxel schedules in a 2x2 design in primary breast cancer - First results of the GeparX study. Cancer Res., 80 (4). PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 1538-7445
Blohmer, Jens-Uwe, Link, Theresa, Reinisch, Mattea, Just, Marianne, Untch, Michael, Stotzer, Oliver, Fasching, Peter A., Schneeweiss, Andreas, Wimberger, Pauline, Seiler, Sabine, Huober, Jens, Thill, Marc, Jackisch, Christian, Rhiem, Kerstin, Solbach, Christine, Hanusch, Claus, Seither, Fenja, Denkert, Carsten, Engels, Knut, Nekljudova, Valentina and Loibl, Sibylle (2022). Effect of Denosumab Added to 2 Different nab-Paclitaxel Regimens as Neoadjuvant Therapy in Patients With Primary Breast Cancer The GeparX 2 x 2 Randomized Clinical Trial. JAMA Oncol., 8 (7). S. 1010 - 1019. CHICAGO: AMER MEDICAL ASSOC. ISSN 2374-2445
Schneeweiss, Andreas, Moebus, Volker, Tesch, Hans, Hanusch, Claus, Denkert, Carsten, Luebbe, Kristina, Huober, Jens, Klare, Peter, Kuemmel, Sherko, Untch, Michael, Kast, Karin, Jackisch, Christian, Thomalla, Joerg, Ingold-Heppner, Barbara, Blohmer, Jens-Uwe, Rezai, Mahdi, Frank, Matthias, Engels, Knut, Rhiem, Kerstin, Fasching, Peter Andreas, Nekljudova, Valentina, von Minckwitz, Gunter and Loibl, Sibylle (2019). Intense dose-dense epirubicin, paclitaxel, cyclophosphamide versus weekly paclitaxel, liposomal doxorubicin (plus carboplatin in triple-negative breast cancer) for neoadjuvant treatment of high-risk early breast cancer (GeparOcto-GBG 84): A randomised phase III trial. Eur. J. Cancer, 106. S. 181 - 193. OXFORD: ELSEVIER SCI LTD. ISSN 1879-0852